Compare · BRLI vs EUCR
BRLI vs EUCR
Side-by-side comparison of Brilliant Acquisition Corporation (BRLI) and Eucrates Biomedical Acquisition Corp. (EUCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BRLI and EUCR operate in Blank Checks (Finance), so they compete in similar markets.
Brilliant Acquisition Corporation
Brilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest BRLI
- SEC Form SC 13G filed by Brilliant Acquisition Corporation
- Brilliant Acquisition Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Brilliant Acquisition Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Brilliant Acquisition Corporation filed SEC Form 8-K: Other Events
- Brilliant Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
- SEC Form NT 10-K filed by Brilliant Acquisition Corporation
- SEC Form 25-NSE filed by Brilliant Acquisition Corporation
- Nukkleus Inc. Closes Merger with Brilliant Acquisition Corporation
- Brilliant Acquisition Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure
- Brilliant Acquisition Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)